HOW TO MAKE MONEY: Algernon Pharmaceuticals (CSE:AGN)(AGNPF)

HOW TO MAKE MONEY: Algernon Pharmaceuticals (CSE:AGN)(AGNPF) – RICH TV LIVE – MARCH 8, 2020 – Algernon Pharmaceuticals Inc. (CSE:AGN) (AGW.F) (AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it will set aside some of its NP-120 (Ifenprodil) drug supply from its planned phase 2 study for idiopathic fibrosis and chronic cough, to make it available on a compassionate use basis, to physicians and their patients with the most serious cases of coronavirus.

Hey guys how you doing this is rich i’m rich to be live and you know i always tell you guys to invest in the best because the best is blessed i got to give it out to dylan fraser man he brought me this pic and i have a feeling it’s gonna blow allergen pharmaceuticals at 15 cents up 66% on friday and they’ve got some big news guys symbol in america ag npf symbol

In canada a gn both the american and canadian symbol exploded on friday and the symbol in frankfurt germany agw another potential big winner another big winner it’s true check this out look at the big news this came out after market after market on friday allergen algernon pharmaceuticals inc agn in canada a gw in frankfurt a gnp f in america a clinical stage

From a suitable development company is pleased to announce it will set aside some of its np 120 – protal drug supply from its planned phase 2 study of ida pathak fibrosis and chronic cough to make it available on a compassionate use basis to physicians and their patients with the most serious cases of coronavirus you know as soon as you put that word in a press


Release you know that people are going to pay attention the decision was made based on the results of an independent study of eyghon proto which showed a 40% improvement in mortality and significantly reduced acute lung injury a li in a recent h5n1 animal study h5n1 is one of the most lethal form of influenza known with a 53% mortality rate since – protel is an

Already approved drug with a known safety history it can be safely administered to patients without additional preclinical testing i think this is huge news is breaking news if we see a similar response in coronavirus patients as seen in the h5n1 animal study a far more lethal form of influenza we believe that patient outcomes should be significantly improved

Said christopher j morneau ceo of algernon algernon rica welcomes contact from the health organizations and physicians globally to learn more about np – 120 – protal this is huge news management believe that the np – 120 – pro dell is a possible treatment for co vyd – 19 coronavirus is based on historical animal studies and not on human trials you only find

These out first here a rich tv live this is where you get the pics folks you get the pics first from your boy at rich tv live it’s true we bring you the winners first not second not third not v not 55th first it’s true what do you think about what do you think about this stock al gern on pharmaceuticals np – 120 – proto is an n methanol d aspirate ndma receptor

See also  Private Stock Market Membership Group

Glutamate receptor antagonist specifically targeting the nmda – type subunit to be glue – and b – proto also exhibits engan s activity for the sigma-1 receptor a tariff own protein up regulated during endoplasmic reticulum stress although the anti fry bro fibrotic activity of eyghon proto in ipf is not known recent studies have suggested a link between both

Receptors and pathways assorted associated with fibrosis glutamate glu is the main exit exit ettore neurotransmitter which acts as glue to mate receptors in the central nervous system otherwise known as cns but over activation of these receptors can cause several damages to neural cells including death recent studies show that the glutamate agonist method l/d

Aspirate nmda can trigger acute lung injury a li li is direct and indirect injury to alveolar epithelial cells and cappell capillary and dothan l cell causing diffuse pulmonary interst itíll and alveolar and demma an acute hypoxic respiratory respiration failure a li is characterized by reduced lung volume and compliance and imbalance of the ventilation perfusion

Ratio inducing hypoxemia and respiratory distress and its severe stage oxygen index 200 known as acute respiratory distress syndrome or a rds n – 120 – pro doll brand name sura cow was initially developed by sanofi in the 1990s in the french and japanese markets for the treatment of circulatory disorders the drug is generous sized and sold in japan algernon has

Phil filed with new intellectual property rights for np 120 – proto for the treatment of respiratory disease this is absolutely we’re talking about a 12 cent stock in america 15 cents in canada nobody even knows and these guys could potentially be helping the entire world elgin and pharmaceuticals is a clinical stage pharmaceutical development company focused

See also  Canadian Cannabis Company Cronos Group (NASDAQ:CRON) in Talks with Altria Group (NYSE:MO)

On advancing its lead compounds for non-alcoholic steve-o hepatitis net otherwise known as na sh nash chronic kidney disease ckd in float or inflammatory bowel disease ibd and idle pathak pulmonary fibrosis ipf and chronic cough this is breaking news thank you dylan fraser for bringing this news first is your boy rich from mississippi live bringing you the news

A new deadly coronavirus potential explosive pick algernon pharmaceuticals a gn in canada and in america a gnp f and in frankfurt germany ag w if you’re not winning you’re not watching this your boy rich rumors to be live and i’m out peace

Transcribed from video
HOW TO MAKE MONEY: Algernon Pharmaceuticals (CSE:AGN)(AGNPF) By RICH TV LIVE

Scroll to top